Respirology Severe Asthma: Characterization for Individualized Therapy Chapter 4: Anti-IL-5 Therapy and Other Biologics in Severe Asthma J. Mark FitzGerald, MD, FRCPC Professor, Division of Respirology, University of British Columbia, Vancouver, British Columbia Download 17 PowerPoint slides
rheumatology 2017 ACR/ARHP Annual Meeting November 3-8, 2017 — San Diego, California Emerging Options: Moving Toward JAK1 Selectivity in Rheumatoid Arthritis Download 3 PowerPoint slides
Respirology American Thoracic Society (ATS) International Conference 2017 May 19-24, 2017 — Washington, DC Major Study Documents Additional Benefits for Anti-IL-5 Therapies in Severe Asthma Download 4 PowerPoint slides
Respirology European Respiratory Society (ERS) International Congress 2016 September 3-7, 2016 — London, UK New Data Emphasize the Therapeutic Value of Biologics in Control of Severe Eosinophilic Asthma Download 2 PowerPoint slides
Respirology European Respiratory Society (ERS) International Congress 2016 September 3-7, 2016 — London, UK Results From Multinational Phase 3 Trials: Benefit of Depleting Eosinophils in Severe Asthma Reinforced with New Biologic Download 6 PowerPoint slides
Respirology American Thoracic Society (ATS) 2016 International Conference May 15-18, 2016 — San Francisco, California Biomarkers of Severe Asthma May Help Better Direct Emerging Therapies Download 2 PowerPoint slides
rheumatology American College of Rheumatology (ACR) 2015 Congress November 6-11, 2015 — San Francisco, California Expansion in Biologic Option Critical For Non-Responders to TNF Inhibitors Download 2 PowerPoint slides
Respirology CHEST Annual Meeting 2015 October 24-28, 2015 — Montreal, Quebec One Size Does Not Fit All in the Treatment of Asthma Download 2 PowerPoint slides
Respirology European Respiratory Society (ERS) International Congress 2015 September 26-30, 2015 — Amsterdam, The Netherlands Concrete Steps Taken to Base Severe Asthma Treatment on Molecular Rather than Clinical Phenotypes Download 3 PowerPoint slides